WuXi PharmaTech, Combined with U.S. Firm, Sets Sights on Global Market
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Fresh after acquiring U.S. biologics firm AppTec Laboratory Services, WuXi PharmaTech is pushing to rapidly broaden its scope of operations and widen its customer base worldwide, according to WuXi CEO Li Ge